# 119-sres-930: A resolution expressing support for the recognition of October 2026, as "World Menopause Awareness Month" and for global awareness and access to care during menopausal transition and post-menopause.

119-sres-930, A resolution expressing support for the recognition of October 2026, as "World Menopause Awareness Month" and for global awareness and access to care during menopausal transition and post-menopause., is a 119th Congress bill sponsored by Sen. Blunt Rochester, Lisa [D-DE] (D-DE); status introduced (as of 2026-10-17).

- Canonical: https://policyrisk.com/legislation/119-sres-930
- As of: 2026-10-17
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-sres-930
- Congress: 119
- Title: A resolution expressing support for the recognition of October 2026, as "World Menopause Awareness Month" and for global awareness and access to care during menopausal transition and post-menopause.
- Status: introduced
- Introduced: 2026-09-30
- Sponsor: Sen. Blunt Rochester, Lisa [D-DE] (D-DE)
- Cosponsors: 1
- Policy area: Health
- Touches household money: no
- Last recorded action: 2026-10-17

## Summary

**Raise awareness and expand access to care for menopause.** The resolution would designate October 2026 as World Menopause Awareness Month and October 18 as World Menopause Day, and would encourage federal agencies to share information, support research, and update guidance on menopause care. - Menopausal individuals: Would push agencies to provide clearer info on symptoms and treatments to improve quality of life. Up to three of four women report hot flashes, which last an average of 7 to 9 years. - Workers and employers: Would highlight workplace impacts and possible supports. As many as 40 percent of menopausal women say symptoms interfere with work weekly and lost working time is estimated at $1.8 billion per year. - Federal agencies, clinicians, and researchers: Would be encouraged to update screening tools and treatment guidance and to conduct additional clinical research on menopause and postmenopause. - Public health risks: Would stress that menopause can raise risks for osteoporosis, heart disease, and stroke and note available treatments including hormone therapy, nonhormonal drugs, and low dose antidepressants.

## Cosponsors (1)

- Sen. Booker, Cory A. [D-NJ] (D-NJ), 2026-09-30T00:00:00.000Z

## Related bills

- 119-s-5066: Health Equity and Accountability Act of 2026
- 119-s-3923: Weather Research and Forecasting Innovation Reauthorization Act of 2026
- 119-s-5283: Momnibus Act
- 119-s-3990: PrEP Access and Coverage Act of 2026
- 119-s-2823: FAMILY Act
- 119-s-3869: Healthy Families Act

## Sources
- [119-sres-930 on Congress.gov](https://www.congress.gov/bill/119th-congress/senate-resolution/930)

## Related
- [119-s-5066: Health Equity and Accountability Act of 2026](https://policyrisk.com/legislation/119-s-5066)
- [119-s-3923: Weather Research and Forecasting Innovation Reauthorization Act of 2026](https://policyrisk.com/legislation/119-s-3923)
- [119-s-5283: Momnibus Act](https://policyrisk.com/legislation/119-s-5283)
- [119-s-3990: PrEP Access and Coverage Act of 2026](https://policyrisk.com/legislation/119-s-3990)
- [119-s-2823: FAMILY Act](https://policyrisk.com/legislation/119-s-2823)
- [119-s-3869: Healthy Families Act](https://policyrisk.com/legislation/119-s-3869)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-sres-930 (as of 2026-10-17).